Drug Type Monoclonal antibody |
Synonyms PR-1498487 |
Target |
Action inhibitors |
Mechanism LRRC15 inhibitors(Leucine-rich repeat-containing protein 15 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |


| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | Spain | - |






